Study of Cilofexor in Adults With Primary Sclerosing Cholangitis
Clinical trial NCT03890120 · TERMINATED
Trial details
- NCT number
- NCT03890120
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2022-11-10
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.